세계의 헌팅턴병 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR(복합 연간 성장률) 17.8%로 10억 7,000만 달러로 성장할 것으로 예측됩니다. 예측 기간 동안의 성장은 신경질환 유병률 증가, 사회적 인지도 향상, 건강 관리 지출 증가, R&D 투자 증가, 임상 연구 활동 확대 등의 요인으로 인한 것으로 예측됩니다. 예측기간의 주요 동향으로는 신약의 채용, 다수의 신약의 개발, 혁신적 기술의 출현, 기술의 진보, 첨단 제품에 대한 수요 증가 등이 있습니다.
신경질환의 유병률 증가는 향후 헌팅턴병 시장의 확대를 견인할 것으로 예측됩니다. 신경 질환은 뇌, 척수, 신경에 영향을 미치고 운동 장애, 협조 운동 장애, 감각 장애, 인지 장애 등의 증상을 일으키는 질환입니다. 이러한 질병 증가는 인구 고령화, 환경 독소 노출, 라이프 스타일 변화, 진단 기술의 진보, 사례의 더 나은 감지 및 확인을 가능하게 하는 유전적 요인 등의 요인에 기인합니다. 헌팅턴병은 유전자의 돌연변이로 인한 신경퇴행성 질환으로 운동기능장애, 인지기능 저하, 정신증상을 유발하며, 이들은 모두 시간이 지남에 따라 점차 악화됩니다. 예를 들어, 2023년 3월 미국에 본사를 둔 비영리 건강 단체인 알츠하이머병 협회(Alzheimer's Association)는 670만 명의 65세 이상의 미국인이 현재 알츠하이머형 치매를 앓고 있다고 보고했습니다. 이 질병을 예방하고, 늦추고, 치료하는 획기적인 방법이 없다면, 이 수는 2060년까지 1,380만명으로 증가할 수 있습니다. 이와 같이 신경질환의 유병률이 높아지고 있는 것이 헌팅턴병 시장의 확대에 기여하고 있습니다.
헌팅턴 병 시장의 기업은 증상을 완화하고 질병의 진행을 늦추기 위해 경구 저분자 약물을 포함한 혁신적인 치료법의 창출에 주력하고 있습니다. 2024년 9월, PTC Therapeutics Inc.는 헌팅턴병을 표적으로 하는 PTC518 프로그램에 대해 미국 식품의약국(FDA)으로부터 패스트트랙 지정을 받았습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 헌팅턴병 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 헌팅턴병 시장 : 성장률 분석
- 세계의 헌팅턴병 시장 실적: 규모와 성장, 2019-2024년
- 세계의 헌팅턴병 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 헌팅턴병 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 헌팅턴병 시장 : 치료 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 대증 요법
- 질환 수식 요법
- 기타
- 세계의 헌팅턴병 시장 : 진단별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 자기 공명 영상법(MRI)
- 컴퓨터 단층 촬영(CT) 스캔
- 유전자 검사
- 기타
- 세계의 헌팅턴병 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 비경구
- 기타
- 세계의 헌팅턴병 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 약국
- 온라인 약국
- 소매 약국
- 세계의 헌팅턴병 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원
- 홈케어
- 전문 클리닉
- 기타
- 세계의 헌팅턴병 시장 : 대증 요법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 항정신병제
- 항우울제
- 기분 안정제
- 근육 이완제
- 세계의 헌팅턴병 시장 : 질환 수식 요법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 유전자 침묵 요법
- 줄기세포요법
- 신경보호제
- 세계의 헌팅턴병 시장 : 기타 세분화별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 물리치료
- 작업요법
- 언어요법
제7장 지역별/국가별 분석
- 세계의 헌팅턴병 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 헌팅턴병 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 헌팅턴병 시장 : 경쟁 구도
- 헌팅턴병 시장 : 기업 프로파일
- Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
- Bausch Health Companies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Sun Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Apotex Inc
- Ipsen SA
- Vertex Pharmaceuticals Incorporated
- H. Lundbeck A/S
- Dr. Reddy's Laboratories Ltd.
- Hikma Pharmaceuticals PLC
- Lupin Limited.
- Neurocrine Biosciences Inc.
- Alnylam Pharmaceuticals Inc
- PTC Therapeutics Inc.
- Annexon Inc.
- Voyager Therapeutics Inc.
- Stealth BioTherapeutics Corp.
- Vaccinex Inc.
- SOM Biotech SL
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 헌팅턴병 시장(2029년) : 새로운 기회를 제공하는 국가
- 헌팅턴병 시장(2029년) : 새로운 기회를 제공하는 부문
- 헌팅턴병 시장(2029년) : 성장 전략
제36장 부록
JHS
Huntington's disease is a rare, inherited neurodegenerative condition that causes the gradual degeneration of nerve cells in the brain, resulting in uncontrolled movements, cognitive decline, and emotional disturbances. It is caused by a genetic mutation in the HTT gene and generally manifests in mid-adulthood.
The primary treatment options for Huntington's disease include symptomatic therapy, disease-modifying therapy, and other types of treatments. Symptomatic therapy aims to alleviate symptoms such as movement disorders, psychiatric issues, and cognitive decline, but does not slow the progression of the disease. Diagnosis is made through various methods, including magnetic resonance imaging (MRI), computed tomography (CT) scans, genetic testing, and other diagnostic tools. Medications are delivered through various routes, such as oral, parenteral, and other methods. These drugs are distributed via hospital pharmacies, online pharmacies, and retail pharmacies, and are used by a range of end users, including hospitals, home care services, specialty clinics, and other healthcare providers.
The huntington's disease market research report is one of a series of new reports from The Business Research Company that provides huntington's disease market statistics, including the huntington's disease industry global market size, regional shares, competitors with the huntington's disease market share, detailed huntington's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the huntington's disease industry. This huntington's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The huntington's disease market size has grown rapidly in recent years. It will grow from $0.47 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth during the historic period can be attributed to factors such as heightened awareness of chronic diseases, growing government awareness programs, increased government initiatives to promote awareness of Huntington's disease, a rising geriatric population, and increased research into genetic disorders.
The huntington's disease market size is expected to see rapid growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of neurological disorders, greater public awareness, rising healthcare spending, growing investments in research and development, and an expansion in clinical research activities. Key trends in the forecast period include the adoption of novel drugs, the development of numerous new drugs, the emergence of innovative technologies, advancements in technology, and a rising demand for advanced products.
The growing prevalence of neurological disorders is expected to drive the expansion of the Huntington's disease market in the future. Neurological disorders are conditions that affect the brain, spinal cord, and nerves, resulting in symptoms such as movement, coordination, sensory, or cognitive impairments. The rise in these disorders can be attributed to factors such as aging populations, exposure to environmental toxins, lifestyle changes, advancements in diagnostic techniques, and genetic factors that enable better detection and identification of cases. Huntington's disease, a neurodegenerative disorder caused by a genetic mutation, leads to motor dysfunction, cognitive decline, and psychiatric symptoms, all of which progressively worsen over time. For example, in March 2023, the Alzheimer's Association, a U.S.-based nonprofit health organization, reported that an estimated 6.7 million Americans aged 65 and older are currently living with Alzheimer's dementia. Without breakthroughs to prevent, slow, or cure the disease, this number could increase to 13.8 million by 2060. This growing prevalence of neurological disorders is thus fueling the growth of the Huntington's disease market.
Companies in the Huntington's disease market are focusing on creating innovative treatments, including oral small molecule drugs, to alleviate symptoms and slow disease progression. These drugs are low-molecular-weight compounds that can be taken orally and are designed to interact with biological targets such as proteins or enzymes to treat diseases. For instance, in September 2024, PTC Therapeutics Inc., a U.S.-based pharmaceutical company, received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its PTC518 program, which targets Huntington's disease. This designation is given to therapies addressing significant unmet medical needs, underlining the potential of PTC518 as a disease-modifying treatment for individuals with this genetic disorder.
In December 2024, PTC Therapeutics, Inc. entered into a partnership with Novartis AG to expedite the development of PTC518 as an oral treatment for Huntington's disease. Novartis AG, a pharmaceutical company based in Switzerland, specializes in providing treatments such as branaplam (LMI070) for Huntington's disease.
Major players in the huntington's disease market are Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Ipsen S.A., Vertex Pharmaceuticals Incorporated, H. Lundbeck A/S, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc, PTC Therapeutics Inc., Annexon Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Vaccinex Inc., SOM Biotech S.L., Alterity Therapeutics Limited, and Medesis pharma SA.
North America was the largest region in the huntington's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in huntington's disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the huntington's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The huntington's disease market consists of revenues earned by entities by providing services such as medical management, psychological and social support, and physical, occupational, and speech therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The Huntington's disease market also includes sales of tetrabenazine, deutetrabenazine, and antidepressants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Huntington's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on huntington's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for huntington's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The huntington's disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Symptomatic Therapy; Disease-Modifying Therapy; Other Treatment Types
- 2) By Diagnosis: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Genetic Testing; Other Diagnosis
- 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
- 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
- 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Symptomatic Therapy: Antipsychotics; Antidepressants; Mood Stabilizers; Muscle Relaxants
- 2) By Disease-Modifying Therapy: Gene Silencing Therapies; Stem Cell Therapy; Neuroprotective Agents
- 3) By Other Treatment Types: Physical Therapy; Occupational Therapy; Speech Therapy
- Companies Mentioned: Novartis AG; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Huntington's Disease Market Characteristics
3. Huntington's Disease Market Trends And Strategies
4. Huntington's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Huntington's Disease Growth Analysis And Strategic Analysis Framework
- 5.1. Global Huntington's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Huntington's Disease Market Growth Rate Analysis
- 5.4. Global Huntington's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Huntington's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Huntington's Disease Total Addressable Market (TAM)
6. Huntington's Disease Market Segmentation
- 6.1. Global Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Symptomatic Therapy
- Disease-Modifying Therapy
- Other Treatment Types
- 6.2. Global Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT) Scan
- Genetic Testing
- Other Diagnosis
- 6.3. Global Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Routes Of Administration
- 6.4. Global Huntington's Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- 6.5. Global Huntington's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End Users
- 6.6. Global Huntington's Disease Market, Sub-Segmentation Of Symptomatic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antipsychotics
- Antidepressants
- Mood Stabilizers
- Muscle Relaxants
- 6.7. Global Huntington's Disease Market, Sub-Segmentation Of Disease-Modifying Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gene Silencing Therapies
- Stem Cell Therapy
- Neuroprotective Agents
- 6.8. Global Huntington's Disease Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Physical Therapy
- Occupational Therapy
- Speech Therapy
7. Huntington's Disease Market Regional And Country Analysis
- 7.1. Global Huntington's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Huntington's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Huntington's Disease Market
- 8.1. Asia-Pacific Huntington's Disease Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Huntington's Disease Market
- 9.1. China Huntington's Disease Market Overview
- 9.2. China Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Huntington's Disease Market
- 10.1. India Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Huntington's Disease Market
- 11.1. Japan Huntington's Disease Market Overview
- 11.2. Japan Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Huntington's Disease Market
- 12.1. Australia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Huntington's Disease Market
- 13.1. Indonesia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Huntington's Disease Market
- 14.1. South Korea Huntington's Disease Market Overview
- 14.2. South Korea Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Huntington's Disease Market
- 15.1. Western Europe Huntington's Disease Market Overview
- 15.2. Western Europe Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Huntington's Disease Market
- 16.1. UK Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Huntington's Disease Market
- 17.1. Germany Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Huntington's Disease Market
- 18.1. France Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Huntington's Disease Market
- 19.1. Italy Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Huntington's Disease Market
- 20.1. Spain Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Huntington's Disease Market
- 21.1. Eastern Europe Huntington's Disease Market Overview
- 21.2. Eastern Europe Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Huntington's Disease Market
- 22.1. Russia Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Huntington's Disease Market
- 23.1. North America Huntington's Disease Market Overview
- 23.2. North America Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Huntington's Disease Market
- 24.1. USA Huntington's Disease Market Overview
- 24.2. USA Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Huntington's Disease Market
- 25.1. Canada Huntington's Disease Market Overview
- 25.2. Canada Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Huntington's Disease Market
- 26.1. South America Huntington's Disease Market Overview
- 26.2. South America Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Huntington's Disease Market
- 27.1. Brazil Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Huntington's Disease Market
- 28.1. Middle East Huntington's Disease Market Overview
- 28.2. Middle East Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Huntington's Disease Market
- 29.1. Africa Huntington's Disease Market Overview
- 29.2. Africa Huntington's Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Huntington's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Huntington's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Huntington's Disease Market Competitive Landscape And Company Profiles
- 30.1. Huntington's Disease Market Competitive Landscape
- 30.2. Huntington's Disease Market Company Profiles
- 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Huntington's Disease Market Other Major And Innovative Companies
- 31.1. Apotex Inc
- 31.2. Ipsen S.A.
- 31.3. Vertex Pharmaceuticals Incorporated
- 31.4. H. Lundbeck A/S
- 31.5. Dr. Reddy's Laboratories Ltd.
- 31.6. Hikma Pharmaceuticals PLC
- 31.7. Lupin Limited.
- 31.8. Neurocrine Biosciences Inc.
- 31.9. Alnylam Pharmaceuticals Inc
- 31.10. PTC Therapeutics Inc.
- 31.11. Annexon Inc.
- 31.12. Voyager Therapeutics Inc.
- 31.13. Stealth BioTherapeutics Corp.
- 31.14. Vaccinex Inc.
- 31.15. SOM Biotech S.L.
32. Global Huntington's Disease Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Huntington's Disease Market
34. Recent Developments In The Huntington's Disease Market
35. Huntington's Disease Market High Potential Countries, Segments and Strategies
- 35.1 Huntington's Disease Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Huntington's Disease Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Huntington's Disease Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
